X

Stay Connected

Sign Up for Updates

logo_white_GoBoldly.png

Welcome to the future of medicine. Where together, we go boldly.

LEARN MORE
network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
logo_Innovation.png

Learn more about America's biopharmaceutical companies and how they seek to improve patients' lives.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

PhRMA member companies R&D investments hit record high in 2017 - $71.4 billion

By Tim McClung  |    August 9, 2018
PhRMA member companies invested $71.4 billion in research and development (R&D) in 2017, the highest level of investment on record, according to the 2018 PhRMA member annual survey, released in...   Read More

Researchers bring focus on science and medicine to California’s capital city

By Priscilla VanderVeer  |    May 29, 2018
Health care issues are often so highly politicized that it’s easy to lose sight of the people behind the scenes, especially the millions of medical professionals that wake up each morning with a...   Read More

To continue to drive the innovation economy and exports, American biopharmaceutical sector depends on fair trade agreements

By Jay Taylor  |    May 10, 2018
May is World Trade Month, when we celebrate the many American companies exporting products around the world, and growing opportunities here in the U.S.   Read More

New Report: America's biopharmaceutical industry supports 4.7 million jobs

By Nick McGee  |    March 1, 2018
Every day, America’s biopharmaceutical sector supports the jobs of 4.7 million men and women across the country while working to discover and deliver new treatments and cures for patients across...   Read More

Guest Post: Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey

By Guest Contributor  |    July 24, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

New PhRMA resources chock full of biopharma industry facts

By John Corea  |    July 20, 2017
Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for...   Read More

New medicines are part of the solution to hold down future health care costs

By Amey Sutkowski  |    June 28, 2017
Innovative medicines improve patient outcomes and can yield significant economic savings. The introduction of a medicine by 2020 that delays the onset of Alzheimer’s disease by just five years...   Read More

New report highlights impact of intellectual property on U.S. economy

By Mark Grayson  |    October 13, 2016
In late September, the U.S. Department of Commerce released a comprehensive report that found intellectual property (IP) intensive industries contribute more than $6 trillion (38.2 percent) to...   Read More

Nearly 4.5 million jobs and counting

By Priscilla VanderVeer  |    May 17, 2016
At PhRMA, we have the honor of highlighting the hope that America’s biopharmaceutical companies bring to patients in the form of innovative treatments and cures. But beyond the value that...   Read More

PhRMA member companies invested $58.8 billion in R&D in 2015

By Stephen J. Ubl  |    May 12, 2016
For more than 30 years, the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, driving innovation for patients. And PhRMA member companies continue to...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Most Popular Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004